EUR/USD 1.14667
0.129%
Gold 4846.40
0.582%
Oil 98.580
-0.285%
USD/JPY 159.771
-0.053%
GBP/USD 1.32700
0.103%
GBP/JPY 212.020
0.110%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On March 19th, a research report from CICC stated that the Federal Reserves decision to maintain interest rates at its March meeting was in line with market expectations. The dot plot and economic forecasts indicate upward revisions to inflation expectations and a narrowing of the room for rate cuts, suggesting a cautious overall policy stance. Although Powell believes the uncertainty surrounding oil price shocks is significant and the economy remains resilient, we believe the actual situation is more complex. Tariffs and immigration policies have already constrained supply, and coupled with the oil price shock, the US economy is entering a "stagflation-like" phase. Simultaneously, private lending risks are emerging, and financial conditions may tighten spontaneously. Against this backdrop, the Fed may remain on hold in the short term due to inflation stickiness; in the medium term, as demand weakens or financial risks escalate, policy will face pressure to passively shift towards rate cuts. We expect the Fed to maintain interest rates unchanged in the first half of the year, with a resumption of rate cuts postponed until the second half. However, if rate cuts are a passive response to a deteriorating economic or financial environment, it will be difficult to boost market risk appetite.Market news: HSBC is considering large-scale layoffs in a multi-year restructuring driven by artificial intelligence.Samsung Electronics shares fell 4%, and SK Hynix shares fell 4.2%.According to the Wall Street Journal, sources say India has purchased more than 30 million barrels of unsold Russian oil. More deals are expected soon.March 19 (Futures News) – According to foreign media reports, Chicago Board of Trade (CBOT) corn futures closed higher on Wednesday, with the benchmark contract rising by about 2%, mainly reflecting the strength of Brent crude oil futures and the potential reduction in U.S. corn planting area this spring. A research report released by Bank of America indicates that the agricultural futures market has not yet fully felt the full impact of the turmoil in the Strait of Hormuz. The ripple effect caused by the sharp fluctuations in crude oil and natural gas prices has begun to transmit to the cost side of agricultural inputs such as fertilizers and fuels. If fertilizer prices remain high and supply tightens, the expected yield of major crops such as U.S. corn may face severe challenges. According to a survey of farmers conducted by Allendale, the U.S. corn planting area this year is expected to be approximately 93.68 million acres, a decrease of 5.12 million acres from last year, and also lower than the 94 million acres predicted by the U.S. Department of Agriculture at a forum last month.

Goldman Sachs Has Improved Humana's Competitive Standing

Aria Thomas

Dec 14, 2022 10:41

2.png


Goldman Sachs analysts upgraded shares of Humana (NYSE:HUM) to Buy with a $652 price target in a research note published on Tuesday.


The company's improved "competitive positioning in MA and underappreciated HC Services opportunity should outweigh the potential RADV impact," which Goldman Sachs estimates to range between $2.6 and $5.8 billion (NPV) before offsetting factors.


Analysts stated, "We see a strengthening earnings outlook as a result of improved competitive positioning in Massachusetts, which has reaccelerated member growth for 2023 and could lead to multiple years of share gains in 2024 when many competitors will face Stars headwinds." "We also see an attractive and undervalued opportunity in the health care services sector, with primary care earnings having the potential to outperform its September guidance,"


While analysts assert that the company is aware of the significant risk posed by the forthcoming RADV ruling, their EPS estimates for 2024-2025 are 4% higher than the industry average.


This reflects "3% higher member growth and a primary care EBITDA opportunity of $205mn-$395mn for 2025," which is "above the company's $100-$200mn outlook in its mid-term guidance, with more of this EBITDA hitting the P&L as WCAS centers come onto the balance sheet."


"Despite the stock's outperformance in 2022 (+18% YTD vs. MCO group +13%), the stock trades in line with its historical median despite higher forward EPS CAGR of 15% vs. its 3-year history of 12%," concluded the analysts.

Suggestion